Assessing the efficacy of peripherally acting mu-opioid receptor antagonists (PAMORAs) in the treatment of opioid-induced constipation
- PMID: 29884613
- DOI: 10.1136/gutjnl-2018-316824
Assessing the efficacy of peripherally acting mu-opioid receptor antagonists (PAMORAs) in the treatment of opioid-induced constipation
Keywords: clinical trials; constipation; pharmacology.
Conflict of interest statement
Competing interests: MC has conducted research on naloxegol and alvimopan, and served as adviser on naldemedine and naloxegol with financial remuneration to his employer, Mayo Clinic, not to him personally.
Comment in
-
Assessing the efficacy of peripherally acting µ-opioid receptor antagonists (PAMORAs) in the treatment of opioid-induced constipation: authors reply.Gut. 2019 Aug;68(8):1530-1531. doi: 10.1136/gutjnl-2018-316977. Epub 2018 Jul 6. Gut. 2019. PMID: 29980606 No abstract available.
Comment on
-
Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and network meta-analysis.Gut. 2019 Mar;68(3):434-444. doi: 10.1136/gutjnl-2018-316001. Epub 2018 May 5. Gut. 2019. PMID: 29730600
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials